KCT0000658招募中未知
Randomized, single blind, controlled, multicenter, comparative clinical study to evaluate and compare clinical and microbiological efficacies between cefotaxime and cefuroxime, when administered intravenously to women with community-acquired acute pyelonephritis
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 832
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- Female
入选标准
- •women with community-acquired acute pyelonephritis
- •age: above 19 years old
排除标准
- •hospital-acquired infection
研究者
相似试验
尚未招募
1 期
Randomized, controlled, double-blind, multicenter, prospective clinical study and mechanism exploration of Qinggan Sanjie Xiaoying Decoction in treating Hashimoto's thyroiditisHashimoto's thyroiditisITMCTR2200006524Sun Simiao Hospital of Beijing University of traditional Chinese Medicine
招募中
Unknown
Randomised, multicentre, controlled, double-blind, prospective study to evaluate the superiority of the Smoke Free App compared to standard therapy in dependent smokersF17Mental and behavioural disorders due to use of tobaccoDRKS00031140Smoke Free 23 GmbH1,442
进行中（未招募）
不适用
Multicenter, Double-Blind, Randomized, Controlled, Parallel Comparison of Efficacy and Safety of Fixed Doses of Two Formulations of Botulinum Toxin Type A in the Treatment of Moderate to Severe Cervical Dystonia (BOTOX® 200 Units and Dysport® 750 Units)EUCTR2006-006449-14-DEAllergan Inc.160
进行中（未招募）
1 期
Fluorescence for the delineation of primary and recurrent tumor and metastases in patients undergoing curative surgery for colorectal cancer.Patients undergoing curative surgery for colorectal cancerMedDRA version: 21.0Level: PTClassification code 10010030Term: Colorectal cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10010035Term: Colorectal cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10010034Term: Colorectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000151-40-DESurgimab300
进行中（未招募）
1 期
Fluorescence for the delineation of primary and recurrent tumor and metastases in patients undergoing curative surgery for colorectal cancer.Patients undergoing curative surgery for colorectal cancerMedDRA version: 21.0Level: PTClassification code 10010030Term: Colorectal cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10010035Term: Colorectal cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10010034Term: Colorectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000151-40-NLSurgimab300